Related Experiment Video
Updated: May 15, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army
Bancha Satirapoj1, Ouppatham Supasyndh, Natee Mayteedol
1Division of Nephrology, Phramongkutklao Hospital, College of Medicine, Bangkok, Thailand. satirapoj@yahoo.com
Insights
Overweight and obesity are significantly linked to chronic kidney disease (CKD) in Thai adults. Higher body mass index (BMI) increases CKD risk, independent of other health factors.
Area of Science:
- Public Health
- Nephrology
- Epidemiology
Background:
- Obesity is a growing concern, particularly in individuals with cardiovascular disease and chronic kidney disease (CKD).
- Understanding the relationship between body mass index (BMI) and CKD is crucial for public health initiatives.
Purpose of the Study:
- To investigate the association between body mass index (BMI) and the prevalence of chronic kidney disease (CKD) in a Thai population.
- To determine if overweight and obesity are risk factors for CKD in this demographic.
Main Methods:
- A general health screening was conducted on a large cohort of Thai individuals.
- Body mass index (BMI) was categorized (overweight, weight at risk, obese I, obese II), and abdominal obesity was defined by waist circumference.
- Chronic kidney disease (CKD) was identified by a glomerular filtration rate (GFR) below 60 mL/min/1.73 m², estimated using the MDRD equation.
Main Results:
- The study included 12,348 males and 3,009 females, with a 7.5% prevalence of CKD.
- Individuals with CKD had significantly higher mean BMIs and higher prevalence of overweight and abdominal obesity compared to those without CKD.
- Multivariate analysis revealed that weight at risk, obese I, and obese II were significantly associated with CKD.
Conclusions:
- Overweight and obesity are independently associated with an increased risk of chronic kidney disease (CKD) in the Thai army population.
- These findings highlight the importance of weight management in preventing CKD.
- The association between obesity and CKD was observed independently of other common risk factors like blood pressure and glucose levels.
Aim:
Obesity represents a significant problem in patients with cardiovascular disease and chronic kidney disease (CKD). The aim of the present study was to investigate the association between body mass index (BMI) and CKD in Thai individuals.
Methods:
Participants underwent general health screening. Overweight, weight at risk, obese I and obese II were defined as having a BMI ≥23 kg/m(2), 23-24.9 kg/m(2) , 25-29.9 kg/m(2) and ≥30 kg/m(2), respectively. Waist circumference ≥ 90 cm for men and > 80 cm for women were represented by abdominal obesity. CKD was defined as a glomerular filtration rate (GFR) < 60 mL/min per 1.73 m(2). An estimate of the GFR was obtained by the four-variable Modification of Diet in Renal Disease (MDRD) equation.
Results:
The study population had 12 348 males and 3009 females. The survey population had a 7.5% prevalence of CKD. There was also a significant graded relationship between the degrees of overweight with the prevalence of CKD. Mean BMI were 25.36 ± 3.29 kg/m(2) for CKD subjects and 24.04 ± 3.13 kg/m(2) for non-CKD subjects (P < 0.001). Prevalence of overweight and abdominal obesity in the participants with CKD were found to be higher than in those without CKD (overweight, 77.6% vs. 61.6%, P < 0.001; abdominal obesity, 35.7% vs. 25.3%, P < 0.001). In a multivariate logistic regression analysis, weight at risk (adjusted odds ratio 1.29; 95% CI 1.07-1.54), obese I (adjusted odds ratio 1.58; 95% CI 1.33-1.87) and obese II (adjusted odds ratio 1.65; 95% CI 1.24-2.19) were associated with CKD.
Conclusion:
Our data showed that overweight and obesity were associated with CKD in Thai members of the army population and their relatives undergoing a general health screening, independently of age, gender, blood pressure, serum lipid, uric acid and glucose levels.
Related Concept Videos
Drug Dosing: Obese Patients
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Chronic Kidney Disease I: Introduction
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...

